Policies & Regulations

Can U.S. Autonomy Clash with Global Health Cooperation?
Management & Administration Can U.S. Autonomy Clash with Global Health Cooperation?

In a significant decision contrasting previous administrative support, the Trump Administration renounced the World Health Organization's 2024 amendments to the International Health Regulations. These amendments were meticulously crafted to enhance global pandemic preparedness following the

Is Medical Tourism for Weight Loss Safe Without Regulation?
Management & Administration Is Medical Tourism for Weight Loss Safe Without Regulation?

The growing trend of medical tourism, particularly for bariatric and weight reduction surgeries, has raised significant concerns regarding its safety and ethical implications. As global obesity rates climb and healthcare systems grapple with capacity constraints, individuals increasingly look

Can Political Shifts Derail America's Cancer Research Achievements?
Clinical & Pharma Can Political Shifts Derail America's Cancer Research Achievements?

In what many regard as a formidable challenge for one of the world’s leading cancer research centers, political decisions over recent years have left the National Cancer Institute (NCI) grappling with significant operational disruptions. Historically pivotal in spearheading notable strides against

Senate Passes Divisive Healthcare and Tax Reconciliation Bill
Tech & Innovation Senate Passes Divisive Healthcare and Tax Reconciliation Bill

In a remarkable display of political theater, the Senate recently accomplished a significant legislative feat in American politics, passing a major healthcare and tax reconciliation bill by an intensely close margin of 51-50. Vice President J.D. Vance's decisive tiebreaking vote underscored the

Improving Vaccine Safety: Challenges and Reforms Needed
Clinical & Pharma Improving Vaccine Safety: Challenges and Reforms Needed

Research into vaccine safety has gained critical importance in recent years, particularly following the widespread deployment of COVID-19 vaccinations. Dual challenges have emerged, involving inadequate monitoring of adverse effects and insufficient compensation for those affected. These challenges

Can CDC's Crisis Undermine HIV Research Progress?
Clinical & Pharma Can CDC's Crisis Undermine HIV Research Progress?

The Centers for Disease Control and Prevention (CDC) has recently faced considerable disruption, raising alarm and uncertainty across the spectrum of ongoing HIV research initiatives. The upheaval started with abrupt layoffs of several key HIV specialists, only to be followed by sudden

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later